Announcements Trials
Browse Landscape

Phase

Phase NA 5

Status

Completed 41Unknown 20Recruiting 11Terminated 7Withdrawn 5Not yet recruiting 2Active not recruiting 1

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 4Genitourinary 1

Conditions

Carcinoma, Hepatocellular 2Prostatic Neoplasms 1Pancreatic Adenocarcinoma Resectable 1Cholangiocarcinoma 1Bile Duct Neoplasms 1

Interventions

Radiotherapy 91pembrolizumab 88Cyclophosphamide 84Gemcitabine 70Cisplatin 70Magnetic Resonance Spectroscopy 65Carboplatin 60Radiosurgery 55Paclitaxel 55Nivolumab 48Dexamethasone 45Bevacizumab 42Biopsy 41Fluorouracil 39durvalumab 37Surveys and Questionnaires 36Docetaxel 36fludarabine 35Doxorubicin 35Radiation 33Oxaliplatin 33Capecitabine 33Rituximab 32fludarabine phosphate 31Leucovorin 31Cytarabine 30Melphalan 29Etoposide 28Pemetrexed 27Irinotecan 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Withdrawn × OTHER × Electroporation × Clear all
NCT04717687 2022-07-13

HOPE

Poitiers University Hospital

Phase NA Withdrawn
Gastrointestinal

Cholangiocarcinoma

NCT03337997 2021-05-06

A Pilot Study of IRE for Resectable Pancreatic Cancer

University of Saskatchewan

Phase NA Withdrawn
Gastrointestinal

Pancreatic Adenocarcinoma Resectable

NCT04404647 2021-03-26

Irreversible Electroporation of Unresectable Liver Tumors

Aalborg University Hospital

Phase NA Withdrawn
Gastrointestinal

Bile Duct Neoplasms, Carcinoma, Hepatocellular

NCT03040453 2020-11-30

IRAL

Karolinska Institutet

Phase NA Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular

NCT02430649 2020-05-27

IRE

Fuda Cancer Hospital, Guangzhou

Phase NA Withdrawn
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡